[Serotoninergic conception of myoclonic syndromes. (Review)].
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D002230:Carbidopa / Q000627:therapeutic use; D004285:Dogs; D004569:Electroencephalography; D004576:Electromyography; D006168:Guinea Pigs; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D009207:Myoclonus / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D011903:Raphe Nuclei / Q000378:metabolism; D012154:Reticular Formation / Q000502:physiology; D012701:Serotonin / Q000032:analysis / Q000378:metabolism* / Q000633:toxicity; D013116:Spinal Cord / Q000378:metabolism; D009435:Synaptic Transmission
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan; D002230:Carbidopa
Serotoninergicheskaia kontseptsiia mioklonicheskikh sindromov. (Obzor).